articleNew England Journal of MedicineAug 29, 2012BRONZE OA

MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia

Harvard University · Dana-Farber Cancer Institute · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

Waldenström's macroglobulinemia is an incurable, IgM-secreting lymphoplasmacytic lymphoma (LPL). The underlying mutation in this disorder has not been delineated.

Methods

We performed whole-genome sequencing of bone marrow LPL cells in 30 patients with Waldenström's macroglobulinemia, with paired normal-tissue and tumor-tissue sequencing in 10 patients. Sanger sequencing was used to validate the findings in samples from an expanded cohort of patients with LPL, those with other B-cell disorders that have some of the same features as LPL, and healthy donors.

Citation impact

1,269
total citations
FWCI
41.19
Percentile
100%
References
36
Citations per year

Authors

19

Topics & keywords

Keywords
  • Waldenstrom macroglobulinemia
  • Macroglobulinemia
  • Lymphoplasmacytic Lymphoma
  • Medicine
  • Gammopathy
  • Immunoglobulin M
  • Sanger sequencing
  • Bone marrow
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.